Verrica Pharmaceuticals I...

NASDAQ: VRCA · Real-Time Price · USD
5.46
-0.28 (-4.88%)
At close: Aug 22, 2025, 3:58 PM
5.51
0.82%
After-hours: Aug 22, 2025, 07:28 PM EDT
-4.88%
Bid 5.31
Market Cap 51.62M
Revenue (ttm) 14.7M
Net Income (ttm) -48.6M
EPS (ttm) -7.74
PE Ratio (ttm) -0.71
Forward PE -2.59
Analyst Hold
Ask 5.8
Volume 50,306
Avg. Volume (20D) 51,812
Open 5.78
Previous Close 5.74
Day's Range 5.40 - 5.78
52-Week Range 3.82 - 29.70
Beta 1.92

About VRCA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRCA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VRCA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Verrica Pharmaceuticals has released their quartely earnings on Aug 12, 2025:
  • Revenue of $12.7M exceeds estimates by $8.14M, with 145.35% YoY growth.
  • EPS of 0.25 exceeds estimates by 1.03, with 180.65% YoY growth.
  • Next Earnings Release

    Verrica Pharmaceuticals Inc. is scheduled to release its earnings on Nov 3, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -4.99%
    VRCA stock has given up its prior gain. Verrica Ph... Unlock content with Pro Subscription
    1 month ago
    -4.99%
    Verrica Pharmaceuticals shares are trading higher after the company reported record growth for its YCANTH applicator.